Seungpil H. Jung

Seoul St. Mary's Hematology Hospital
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Healthcare Jurisdiction as a Determinant of Real-World Survival in Transplant-Ineligible Multiple Myeloma: Lessons From a Three-Country East Asian Comparison.

Healthcare Jurisdiction as a Determinant of Real-World Survival in Transplant-Ineligible Multiple Myeloma: Lessons From a Three-Country East Asian Comparison.

Journal: European journal of haematology

Published: May 17, 2026

Risk prediction of traumatic and non-traumatic subdural hematoma after ischemic stroke: a nationwide competing-risk model with external validation.

Risk prediction of traumatic and non-traumatic subdural hematoma after ischemic stroke: a nationwide competing-risk model with external validation.

Journal: Neurosurgical review

Published: January 27, 2026

Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.

Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.

Journal: Annals of hematology

Published: January 02, 2026

Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65-69 Years (CAREMM-2110 study).

Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65-69 Years (CAREMM-2110 study).

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 19, 2025

Real-World Outcomes of Tisagenlecleucel Versus Standard-of-Care Salvage Chemotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis From Korea.

Real-World Outcomes of Tisagenlecleucel Versus Standard-of-Care Salvage Chemotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis From Korea.

Journal: Journal of Korean medical science

Published: September 11, 2025

Development and multinational validation of a multiple myeloma-specific comorbidity index using real-world cohorts: CAREMM-2108.

Development and multinational validation of a multiple myeloma-specific comorbidity index using real-world cohorts: CAREMM-2108.

Journal: Blood cancer journal

Published: August 26, 2025

Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study.

Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study.

Journal: Blood cancer journal

Published: May 02, 2025

Phyllodes tumors of the breast: a comprehensive review.

Phyllodes tumors of the breast: a comprehensive review.

Journal: Annals of surgical treatment and research

Published: April 16, 2025

Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party KMMWP-174 study.

Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party KMMWP-174 study.

Journal: Haematologica

Published: March 22, 2025

Systemic chemotherapy in metastatic TNBC polarizes effector T cell differentiation.

Systemic chemotherapy in metastatic TNBC polarizes effector T cell differentiation.

Journal: Cancer cell international

Published: March 06, 2025

Cost-Effectiveness Analysis of Daratumumab Monotherapy and Subsequent Therapies in Heavily Treated Relapsed/Refractory Multiple Myeloma: A Feasible Methodology using a Korean Nationwide Population Cohort.

Cost-Effectiveness Analysis of Daratumumab Monotherapy and Subsequent Therapies in Heavily Treated Relapsed/Refractory Multiple Myeloma: A Feasible Methodology using a Korean Nationwide Population Cohort.

Journal: Cancer research and treatment

Published: January 10, 2025

Risk factors and predictive models about false-negative urine dipstick results in albuminuria patients: population-based study from Korea National Health and Nutrition Examination Survey 2019 to 2022.

Risk factors and predictive models about false-negative urine dipstick results in albuminuria patients: population-based study from Korea National Health and Nutrition Examination Survey 2019 to 2022.

Journal: Kidney research and clinical practice

Published: October 10, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026